Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 279-815-0 | CAS number: 81782-77-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 25
- Absorption rate - inhalation (%):
- 100
Additional information
No toxicokinetic studies are available that directly address absorption, distribution, metabolism, or excretion of 4-methyl-3-decen-5-olfollowing oral administration; however information is available from existing toxicology studies and the physical chemical properties to infer potential toxicokinetic properties. The extent of dermal absorption through human skin was determined in a fully compliant in vitro study, performed according to OECD 428.
Toxicological end points for4-methyl-3-decen-5-ol
Acute oral toxicity (mouse) | LD50 >8000 (united not reported; mg/kg bw assumed) |
Acute dermal toxicity | LD50 >5000 mg/kg |
Acute IP toxicity (mouse) | 1000 < LD50 < 2000 (units not reported; mg/kg bw assumed) |
In vivo skin irritation | Non irritant |
In vivo eye irritation | Non irritant |
Skin sensitisation (OET) | Not a skin sensitiser |
Skin sensitisation (HRIPT) | Not a skin sensitiser |
In vitro gene mutation/Ames | Negative |
In vitro cytogenicity | Negative |
Micronucleus | Negative |
Repeat dose (16 week, diet) | NOAEL 10000 ppm |
Repeat dose (27 week, diet) | NOAEL 1000 ppm |
Reproduction/developmental screening test (OECD 421), dermal | 0, 50, 150 and 300 mg/kg bw/day NOAELs parental systemic = 300 mg/kg bw/day reproduction = 300 mg/kg bw/day developmental = 300 mg/kg bw/day |
In vitro dermal absorption | |
Bioaccumulation factor | 174 L/kg |
Significance of routes of exposure
Oral route: this is not considered a relevant route for occupational exposure or for the general population. Slight exposure may occur via accidental hand-to-mouth contact, but this is not expected to contribute significantly to exposure.
Inhalation route: the substance has a low vapour pressure and a high boiling point and therefore is unlikely to volatilize or be released into the air. Under conditions of normal handling and use, the substance will not be aerosolized. Water solubility is low and this can enhance penetration to the inner respiratory tract however, absorption would occur mainly via micellular solubilisation because the high lipophilicity.
Dermal route:this is considered to be the principal route for occupational exposure, and also for exposure of the general population.
Absorption
The main physical chemical properties that influence absorption are molecular weight, and water and lipid solubility. The substance has a molecular weight of 170, a water solubility of 63 mg/L at 20°C and Log Kow of 3.9. All these properties suggest 4-methyl-3-decen-5-ol would be absorbed by the gastro-intestinal tract following oral exposure and become systematically available because the substance is able to dissolve to some extent and permeate the cell membrane. Acute oral toxicity study showed low inherent systemic toxicity.
Based on the low vapour pressure (1.1 Pa at 25°C) 4-methyl-3-decen-5-ol is unlikely to volatilize or be released into the air. However, the moderate water solubility and optimal Log Pow indicate inhalation as another possible route of absorption. It is likely that4-methyl-3-decen-5-olwill be absorbed if inhaled, based on available toxicity data showing a degree of bioavailability after oral exposure. As a worst-case assumption, inhalation absorption of 4-methyl-3-decen-5-ol is considered high for risk assessment purposes.
Dermal absorption is also likely, because 4-methyl-3-decen-5-ol is a liquid, molecular weight is not excessive and lipophilicity appropriate for allowing the substance to cross the stratum corneum of the skin. On the other hand, water solubility suggests that permeation through the stratum corneum into the epidermis would be low to moderate.
The results of the acute dermal toxicity study performed in rabbits, the skin of which are known to be more permeable than that of rats, thus even more permeable than human skin (US EPA Dermal Exposure Assessment: Principles and Applications EPA/600/8-91/011B January 1992 Interim Report) confirms that 4-methyl-3-decen-5-ol possess low toxicity also following dermal exposure, with the LD50 value obtained in this study was in excess of 5000 mg/kg. Repeat-dose dermal studies in rats with an analogous substance also showed no evidence of systemic toxicity at dose levels up to 450 mg/kg bw/day. For purposes of risk assessment, a default value for dermal penetration is assumed (25%) .
Distribution
Any 4-methyl-3-decen-5-ol that is absorbed will be distributed via the blood to the liver and other organs and tissues.No target organs are identified from toxicity studies; the bioconcentration factor is calculated to be moderate so no marked bioaccumulation is expected.
Metabolism and potential for bioaccumulation
Based on its chemical structure,4-methyl-3-decen-5-ol may be metabolized at least via oxidative metabolism. Due to the small molecular size, it is feasible that elimination will be quite rapid via urine, thus limiting the degree of metabolism. Metabolism may therefore be incomplete.
The structure of the substance provides information that helps predicts the probable metabolic pathways. The OECD Toolbox (version 2.3) liver, skin, and microbial metabolism simulators predict 63 metabolites for the liver, 4 metabolites for the skin and 103 metabolites for microbial metabolism. The structure of liver metabolites suggests that changes would involve mainly the side-chain, which will be subjected to beta-oxidation, and most of the 63 liver metabolites are likely to represent intermediate metabolites. As the side chain contains odd number of carbon (9-11), propionyl-CoA in addition to acyl-CoA would be produced. Both will enter into the citric acid cycle and form a source of energy. It is expected that the terminal metabolite obtained after the side chain has been metabolized, can be conjugated and excreted. Considering the number of metabolites the OECD Toolbox predicted for microbial metabolism, any unabsorbed substance is expected to be extensively metabolised by the intestinal microflora.
Excretion
No evidence of substance retention or bioaccumulation is predicted, or seen in toxicity studies. Low, molecular weight (below 200) suggests that excretion will be mainly via the urine, and may be rapid. The same would occur for metabolites generated by the liver. Although toxicity including mortality is reported in acute studies, no duration of symptoms or time of death is reported so rapidity of elimination cannot be supported by experimental data.
In summary
4-methyl-3-decen-5-ol is inferred to be well absorbed following oral exposure, highly absorbed following inhalation exposure and poorly absorbed following dermal exposure. The absorbed 4-methyl-3-decen-5-ol will be distributed within the body, and metabolised to some extent by the liver. It is not expected that 4-methyl-3-decen-5-ol will bioaccumulate. The urine is likely to be the main route of excretion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.